Source: European journal of cancer. Unidade: FM
Subjects: ENSAIO CLÍNICO, LINFOMA, QUALIDADE DE VIDA, DOENÇAS DO SISTEMA NERVOSO PERIFÉRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DUMMER, Reinhard et al. Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma: Results from the randomised phase III ALCANZA study. European journal of cancer, v. 133, p. 120-130, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.ejca.2020.04.010. Acesso em: 22 ago. 2024.APA
Dummer, R., Prince, H. M., Whittaker, S., Horwitz, S. M., Kim, Y. H., Scarisbrick, J., et al. (2020). Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma: Results from the randomised phase III ALCANZA study. European journal of cancer, 133, 120-130. doi:10.1016/j.ejca.2020.04.010NLM
Dummer R, Prince HM, Whittaker S, Horwitz SM, Kim YH, Scarisbrick J, Quaglino P, Zinzani PL, Wolter P, Sanches Junior JA. Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma: Results from the randomised phase III ALCANZA study [Internet]. European journal of cancer. 2020 ; 133 120-130.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1016/j.ejca.2020.04.010Vancouver
Dummer R, Prince HM, Whittaker S, Horwitz SM, Kim YH, Scarisbrick J, Quaglino P, Zinzani PL, Wolter P, Sanches Junior JA. Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma: Results from the randomised phase III ALCANZA study [Internet]. European journal of cancer. 2020 ; 133 120-130.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1016/j.ejca.2020.04.010